Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment
On January 16, 2026, Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals Inc. (TERN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 5,550,000 | $224,220,000 | +41% | 0.34% |
| 2. | Vivo Capital Albert Cha And Frank Kung | 5,346,928 | $216,015,891 | -23% | 13.96% |
| 3. | Vestal Point Capital Ryan Wilder | 4,500,000 | $181,800,000 | 6.18% | |
| 4. | VenBio Select Advisor Kurt Von Emster | 4,350,000 | $175,740,000 | 1.73% | |
| 5. | Citadel Investment Group Ken Griffin | 3,166,642 | $127,932,337 | +100% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.93 | 5,000 | $19,649.50 | 25,000 | 2025-06-27 | Filing | |
| $3.93 | 5,000 | $19,633.50 | 20,000 | 2025-06-27 | Filing | |
| $3.87 | 23,314 | $90,229.84 | 47,083 | 2025-06-25 | Filing | |
| $3.95 | 5,000 | $19,732.50 | 15,000 | 2025-06-16 | Filing | |
| $3.72 | 5,000 | $18,600.00 | 10,000 | 2025-06-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.80 | 4,083 | $162,501.36 | 288,976 | 2026-02-17 | Filing | |
| $39.22 | 8,159 | $319,963.34 | 293,059 | 2026-02-17 | Filing | |
| $38.07 | 2,341 | $89,114.38 | 301,218 | 2026-02-17 | Filing | |
| $37.53 | 7,521 | $282,230.04 | 288,976 | 2026-01-15 | Filing | |
| $37.02 | 61,228 | $2,266,372.79 | 296,497 | 2026-01-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,194,218 | $331,046,406 | 0.01% | |
| 2. | 7,945,608 | $321,002,599 | 0.02% | |
| 3. | 5,523,948 | $223,167,499 | 0% | |
| 4. | 3,379,569 | $136,495,568 | 0.06% | |
| 5. | 3,045,200 | $123,026,080 | 0.73% |
News See All
11 Best Performing Stocks in the Last 12 Months
The year 2025 was not just another year but a period marked by sharp shifts in technology, geopolitics, and trade policy, often driving markets in surprising ways, according to Reuters' year-end report...
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is among the 14 best booming stocks to buy right now.
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.
Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN)
On December 11, 2025, TheFly reported that Citizens boosted its price goal for Terns Pharmaceuticals, Inc. (NASDAQ:TERN) to $57 from $35.
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential
Terns Pharmaceuticals climbed by 629.64 percent in 2025, primarily boosted by stellar results from the clinical trial of its therapy candidate for chronic myeloid leukemia (CML), which has the potential...
Jim Cramer Was Asked About These 11 Stocks
Jim Cramer, the host of Mad Money, said on Tuesday that he believes the recent shift of money out of artificial intelligence names and into stocks across various sectors has helped support the broader...
Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial
In an updated report earlier in the week, Terns Pharmaceuticals, Inc.
Terns (TERN) Hits All-Time High on Stellar Leukemia Treatment Results
Terns soared to a new all-time high on Monday as investors took heart from the encouraging results of its clinical trial to test the efficacy of drug candidate, TERN-701, in patients with previously treated...
Hedge Fund Resource Center Billionaire Hedge Funds
